Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
3.
Rev. cuba. hematol. inmunol. hemoter ; 33(1): 1-13, ene.-mar. 2017.
Article in Spanish | LILACS, CUMED | ID: biblio-901068

ABSTRACT

El desarrollo de la Medicina Transfusional y la Inmunohematología en el Instituto de Hematología e Inmunología en estas cinco décadas se ha caracterizado por logros relevantes como la introducción de métodos de mayor sensibilidad para optimizar el diagnóstico inmunohematológico, entre ellos los ensayos inmunoenzimáticos, la citometría de flujo y las técnicas de inmovilización de antígenos eritrocitarios y plaquetarios por anticuerpos moclonales específicos (MAIEA y MAIPA, respectivamente); la profundización en el estudio de las citopenias inmunes; la pesquisa de agentes infecciosos en donantes de sangre y pacientes politransfundidos; la producción y distribución de anticuerpos hemoclasificadores poli y monoclonales; la labor de referencia nacional del laboratorio de Inmunohematología; las contribuciones al Programa Nacional de sangre que incluyen la confección y distribución de guías clínicas para el uso de la sangre y de procederes para bancos de sangre y servicios de transfusiones; el desarrollo de métodos de aféresis terapéutica; el desarrollo de investigaciones multicéntricas en Medicina Transfusional; la obtención y procesamiento de células madre hematopoyéticas de médula ósea y sangre periférica para su empleo en trasplantes hematopoyéticos y terapia celular; la formación y actualización de profesionales y técnicos en Medicina Transfusional, tanto en Cuba como en otros países de Latinoamérica y la organización de talleres, eventos e intercambios nacionales e internacionales en estas ramas. Las proyecciones de trabajo se encaminan a introducir técnicas moleculares en Inmunohematología para lograr una mejor caracterización de los anticuerpos contra células sanguíneas, profundizar en el estudio de los anticuerpos contra leucocitos y plaquetas, contribuir al desarrollo de un programa nacional de hemovigilancia, crear un banco de células progenitoras de cordón umbilical para uso terapéutico e iniciar programas de maestrías y doctorados en Medicina Transfusional.


The development of Transfusion Medicine and Immunohematology at the Institute of Hematology and Immunology in these five decades has been characterized by relevant achievements such as the introduction of more sensitive methods to optimize the immunohematological diagnosis such as immunoenzymatic assays, flow cytometry and techniques of immobilization of erythrocyte and platelet antigens by specific monoclonal antibodies (MAIEA and MAIPA, respectively); deepening the study of immune cytopenias; screening for infectious agents in blood donors and polytransfused patients; the production and distribution of polyclonal and monoclonal hemoclastic antibodies, the national reference work of Immunohematology Laboratory; contributions to the National Blood Program such as the preparation and distribution of clinical guidelines for the use of blood and procedures for blood banks and transfusion services; the development of therapeutic apheresis methods; the development of multicentric investigations in Transfusional Medicine; the procurement and processing of hematopoietic stem cells from bone marrow and peripheral blood for use in hematopoietic transplantation and cell therapy; the training and updating of professionals and technicians in Transfusion Medicine, both in Cuba and in other countries of Latin America and the organization of workshops, events and national and international exchanges in these branches. The work projections are aimed at introducing molecular techniques in Immunohematology to achieve a better characterization of the antibodies against blood cells, to deep the study of the antibodies against leukocytes and platelets, to contribute to the development of a national haemovigilance program, to create a bank of umbilical cord progenitor cells for therapeutic use and initiate master's and doctoral programs in Transfusion Medicine.


Subject(s)
Humans , Transfusion Medicine/history , Transfusion Medicine/methods , Hematology
4.
Transfus Clin Biol ; 23(3): 119-26, 2016 Sep.
Article in French | MEDLINE | ID: mdl-27443188

ABSTRACT

Ethics is on the cross road of off values that are present along the ways of transfusion medicine. This is an important tool to afford opinions as well as debates that always emerge when discussing transfusion medicine. The wording is particularly important; this was one among several others that characterized the soul of Jean-Jacques Lefrère when he opened the doors of the ethical issues of transfusion medicine.


Subject(s)
Transfusion Medicine/ethics , Attitude to Health , Blood , Blood Transfusion/ethics , Blood Transfusion/history , Blood Transfusion/psychology , Curriculum , Ethics, Medical/education , Ethics, Medical/history , History, 20th Century , History, 21st Century , Humans , Literature, Modern , Medicine in Literature , Paris , Transfusion Medicine/education , Transfusion Medicine/history , Universities/history
7.
Transfus Clin Biol ; 23(1): 45-8, 2016 Feb.
Article in French | MEDLINE | ID: mdl-26762688

ABSTRACT

The announcement of the death of Professor Jean-Jacques Lefrère caused considerable emotion and surprise within the francophone Africa blood transfusion research network. The group was created in 2007 in Paris. Each member that works within this group wanted to pay their last respects through dedicated publication for a brilliant researcher and writer. The tribute describes the creation of the group, its goals, its operations, its achievements and the prospects of its activities while emphasizing the essential role that Professor Lefrère played within the group.


Subject(s)
Blood Safety/history , Transfusion Medicine/history , Africa, Western , Congresses as Topic/history , France , Goals , History, 20th Century , History, 21st Century , Humans , Information Services/history , Information Services/organization & administration , International Cooperation , Research/history , Research/organization & administration , Societies, Scientific , Transfusion Medicine/organization & administration
8.
Transfus Clin Biol ; 23(1): 55-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26778105

ABSTRACT

The French pioneer for blood transfusion, who eventually organized the very early blood transfusion centers worldwide, went to imagine a scenario written in purpose for Charlie Chaplin, the unique character of "The Tramp" ("Charlot" in French). The movie Star was offered to feature a blood donation propagandist, and no longer the perpetual, well-known, "loser". This anecdote, besides being amusing, tells a lot on how Arnault Tzank encompassed all the difficulties in collecting blood enough to meet the demand, at all times; his proposal turns out to be extremely modern and questions nowadays marketing for blood donation.


Subject(s)
Blood Donors/history , Motion Pictures/history , Propaganda , Transfusion Medicine/history , Altruism , Blood Donors/psychology , France , History, 20th Century , Humans , Societies, Medical
14.
Thromb Res ; 134 Suppl 1: S4-9, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24513149

ABSTRACT

The history of haemophilia dates back to the 2nd century AD, with the first "modern" descriptions of the condition appearing during the 1800s. At that time, transfusion medicine and haemophilia became closely linked, with blood transfusion being the only possible treatment option. A turning point in the history of haemophilia came in the middle of the 20th century when researchers identified an "antihaemophilic globulin" that could reduce the clotting time in haemophilic blood, thereby paving the way for the introduction of cryoprecipitate and the first clotting factor concentrates for the treatment of haemophilia A, haemophilia B and von Willebrand disease. The availability of pasteurized, and therefore virus-safe, plasma-derived, clotting factor concentrates, such as Haemate P(®) and Beriate(®) P in Germany and other countries, dramatically improved the quality of life and life expectancy of haemophilia patients. These and other treatment advances enabled home treatment, with many centres introducing prophylaxis to younger patients. Today, thanks to the support from patient organizations, such as the German Haemophilia Society, which was founded by Prof. Rudolf Marx from Munich, haemophilia patients can be assured of good bleeding control using products with established efficacy and safety profiles. Work on improving factor concentrates continues, with efforts directed towards extending their half-lives using recombinant albumin-fused proteins and other modern technologies. The past 20 years has witnessed major improvements in almost all aspects of haemophilia treatment. It is hoped the next 20 years will add promising new chapters to the haemophilia book of history.


Subject(s)
Hemophilia A/history , Hemophilia A/therapy , Blood Transfusion/history , Blood Transfusion/methods , Drug Discovery , Factor VIII/history , Factor VIII/therapeutic use , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , History, Ancient , History, Medieval , Humans , Transfusion Medicine/history , Transfusion Medicine/methods
16.
Transfusion ; 53(10 Pt 2): 2365-74, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24032622
17.
Transfusion ; 53(10): 2355-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24015964
18.
Transfus Med Rev ; 27(3): 194-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23831199

ABSTRACT

Paul Holland began his career in transfusion medicine in 1963 as an assistant to Dr. Paul Schmidt in the Blood Bank at the National Institutes of Health (NIH). He served at the NIH for 20 years and retired in 1983 with the rank of Captain in the Public Health Service. He subsequently became the Medical Director/CEO of the Sacramento Medical Foundation Blood Center, now Blood Source, a position he held for the next 21 years. Paul Holland has authored/co-authored 265 articles, chapters and monographs, mostly concerning issues relating to either viral hepatitis or HIV. In addition to his research career, Paul was a very active educator, having contributed importantly to the development of many current thought leaders in transfusion medicine. His distinguished career also included important administrative roles in national and international organizations relevant to transfusion medicine. He also was the recipient of many honors and awards which has won him wide-spread renown and the respect of his many colleagues.


Subject(s)
Blood Banks , Transfusion Medicine/history , Transfusion Medicine/methods , California , History, 20th Century , History, 21st Century , Humans , National Institutes of Health (U.S.) , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...